The AIR® pulmonary drug delivery technology offers a unique, proprietary delivery system for optimized drug delivery to the lungs. A major innovation among pulmonary delivery systems, it was first published in the journal Science. This system can provide efficient dry-powder delivery of small molecule, peptide, protein and other macromolecule drug particles to the deep lung, with advantages over other delivery methods:
- Systemic delivery of small molecules, peptides, proteins, and other macromolecules.
- Local or targeted delivery of wide dosage range.
- A small, easy to use delivery device.
- Demonstrated safety and tolerability in human clinical trials.
- Ongoing large-scale trials with both protein therapeutics and small molecule drugs.